WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: ASPERIQ

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on ASPERIQ

Proof of use for ASPERIQ

We do not have any records of a proof of use for ASPERIQ at this moment.

Click here to add a proof of use for ASPERIQ

Possible trademark infringements of ASPERIQ

Basic Information about ASPERIQ

Serial Number
79287376
Filing Date
20 Apr 2020
Registration Number
6624166
Registration Date
25 Jan 2022
Mark Drawing Code
4

Classifications

Declare the trademark use of ASPERIQ on the blockchain with WikiTrademarks.io.

First use of ASPERIQ anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
009
US Codes
021; 023; 026; 036; 038
First use of ASPERIQ anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
037
US Codes
100; 103; 106
First use of ASPERIQ anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
038
US Codes
100; 101; 104
First use of ASPERIQ anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
041
US Codes
100; 101; 107
First use of ASPERIQ anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
042
US Codes
100; 101
First use of ASPERIQ anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
045
US Codes
100; 101

Correspondent

AWA Sweden AB
Matrosgatan 1
SE-200 71 Malmö
Sweden

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on ASPERIQ